Cargando…

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway

BACKGROUND: There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Symptom Checklist (SCL-10) over time. METHODS: Nested prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aas, Christer Frode, Vold, Jørn Henrik, Gjestad, Rolf, Skurtveit, Svetlana, Lim, Aaron Guanliang, Gjerde, Kristian Varden, Løberg, Else-Marie, Johansson, Kjell Arne, Fadnes, Lars Thore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912462/ https://www.ncbi.nlm.nih.gov/pubmed/33639969 http://dx.doi.org/10.1186/s13011-021-00354-1

Ejemplares similares

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway
por: Madebo, Tesfaye, et al.
Publicado: (2022)

Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
por: Vold, Jørn Henrik, et al.
Publicado: (2019)

Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
por: Aas, Christer Frode, et al.
Publicado: (2020)

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
por: Vold, Jørn Henrik, et al.
Publicado: (2022)

Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
por: Aas, Christer F., et al.
Publicado: (2020)

Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
por: Chalabianloo, Fatemeh, et al.
Publicado: (2021)

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway
por: Lygren, Ole Jørgen, et al.
Publicado: (2019)

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
por: Aas, Christer Frode, et al.
Publicado: (2020)

The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Performance of the WHOQOL-BREF among Norwegian substance use disorder patients
por: Muller, Ashley Elizabeth, et al.
Publicado: (2019)

Oral health related quality of life and reasons for non‐dental attendance among patients with substance use disorders in withdrawal rehabilitation
por: Åstrøm, Anne Nordrehaug, et al.
Publicado: (2021)

Confirming the factor structure of a generic quality of life instrument among pre-treatment substance use disorder patients
por: Muller, Ashley Elizabeth, et al.
Publicado: (2019)

Validating the generic quality of life tool “QOL10” in a substance use disorder treatment cohort exposes a unique social construct
por: Muller, Ashley E., et al.
Publicado: (2016)

Associations between psychoactive substance use and sensation seeking behavior among drivers in Norway
por: Jamt, Ragnhild E. G., et al.
Publicado: (2020)

Patients admitted to treatment for substance use disorder in Norway: a population-based case–control study of socio-demographic correlates and comparative analyses across substance use disorders
por: Amundsen, Ellen J., et al.
Publicado: (2022)

Women and Substance Use Disorders
por: Hecksher, Dorte, et al.
Publicado: (2009)

Assessing health service satisfaction among users with substance use disorders within the municipalities in Norway
por: Stallvik, Marianne, et al.
Publicado: (2019)

Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a randomised controlled trial (FruktBAR)
por: Fadnes, Lars T., et al.
Publicado: (2022)

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
por: Dal Farra, Deborah, et al.
Publicado: (2022)

A systematic review of substance use and substance use disorder research in Kenya
por: Jaguga, Florence, et al.
Publicado: (2022)

Nationwide Study of Neuropsychiatric Comorbidity and Medicines Use in Children With Autism Spectrum Disorder in Norway
por: Kiselev, Yury, et al.
Publicado: (2020)

Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis
por: Zhornitsky, Simon, et al.
Publicado: (2015)

Epigenetic Regulation in Substance Use Disorders
por: McQuown, Susan C., et al.
Publicado: (2010)

Patient registries for substance use disorders
por: Tai, Betty, et al.
Publicado: (2014)

Psychiatric Consultation and Substance Use Disorders
por: Specker, Sheila, et al.
Publicado: (2009)

Substance use disorders, trauma, and PTSD
por: Van den Brink, Wim
Publicado: (2015)

Brief intervention in substance use disorders
por: Mattoo, Surendra Kumar, et al.
Publicado: (2018)

Brief Interventions for Substance Use Disorders
por: Sarkar, Siddharth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u7gc7hmvc12abfd83kqo64ete9